scrotal eczema
Conditions
Interventions
Experimental group:topical crisaborole ointment for 2 weeks
control group:topical vaseline for 2 weeks
Sponsors
Dermatology Hospital of Southern Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients with scrotal eczema aged 18 to 65 years; 2. The clinical diagnosis is consistent with scrotal eczema, with limited skin lesions and no obvious exudation; 3. The course of the disease is subacute or chronic; 4. The patients voluntarily participated in the trial, signed the informed consent form, and agreed to conduct timely visits in accordance with the investigator's requirements during the trial.
Exclusion criteria
Exclusion criteria: 1. In patients with acute scrotal eczema, the skin lesions have obvious exudation; 2. Skin lesions with bacterial, fungal or viral infection, or eczema in other parts; 3. Those who are known to have a history of allergies to the test drugs and drugs with similar chemical structures; 4. Those with obvious skin atrophy and red scrotal syndrome at the skin lesions that may affect the judgment of drug safety; 5. Systemic use of steroids, antihistamines and other drugs that may affect the judgment of efficacy in the past 4 weeks; 6. Patients who have used any topical medication for eczema skin disease in the past 2 weeks (including but not limited to: topical hormones, topical calcineurin inhibitors, etc.); 7. Combined with serious heart, cerebrovascular, endocrine and other serious systemic diseases that affect their survival, or malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eczema Area and Severity Index Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| dermoscopy;Dermatological Quality of Life Index Questionnaire; | — |
Countries
China
Contacts
Public ContactChen Rongyi
Dematology Hospital of Southern Medical University
Outcome results
None listed